De Coppi Paolo, Giuliani Stefano, Fusaro Fabio, Zanatta Cinzia, Zacchello Graziella, Gamba Piergiorgio, Zanon Giovanni F
Division of Pediatric Surgery, Department of Pediatrics, University of Padua, Italy.
Transplantation. 2006 Oct 27;82(8):1042-5. doi: 10.1097/01.tp.0000236043.73906.25.
The incidence of donor kidneys with vascular anomalies ranges from 18% to 30%; such kidneys are usually at increased risk of vascular and urological complications. The aim of this study was to determine whether the use of cadaver kidneys with vascular anomalies would adversely affect posttransplant graft and patient outcome.
From October 1987 to January 2004, 241 patients underwent kidney transplantation in our pediatric surgery department. Vascular anomalies were noted in 77/241 grafts (31.9%); 50 (64.9%) had multiple renal arteries and 22 (28.5%) venous anomalies. Patients were divided into three groups: Group A (1 renal artery and vein, 1 arterial and venous anastomosis [n = 161]), Group B (> 1 renal artery or vein, 1 arterial and venous anastomosis [n = 33]), and Group C (> 1 renal artery or vein, > 1 arterial and venous anastomosis [n = 47]). We compared the three groups for: patient and graft survival, incidence of posttransplant acute tubular necrosis, vascular and urological complications, postoperative mean creatinine levels, and posttransplantation hypertension.
We found no significant differences among the three groups regarding episodes of acute rejection or acute tubular necrosis. Creatinine levels reached normal levels within 30 days in all the groups without any significant differences. Furthermore, patient and graft survival were excellent (100% and 97%).
The presence of vascular anomalies and their multiple or complex repair does not represent a theoretical disadvantage even in pediatric patients. In order to maximize the quantity and quality of donor kidneys especially in pediatric population, kidneys with vascular anomalies may be implanted with very little risk.
伴有血管异常的供肾发生率在18%至30%之间;此类肾脏通常发生血管和泌尿系统并发症的风险更高。本研究的目的是确定使用伴有血管异常的尸体肾是否会对移植后移植物及患者的预后产生不利影响。
1987年10月至2004年1月,241例患者在我们小儿外科接受了肾移植。在241个移植物中有77个(31.9%)存在血管异常;50个(64.9%)有多条肾动脉,22个(28.5%)有静脉异常。患者被分为三组:A组(1条肾动脉和静脉,1个动静脉吻合口[n = 161]),B组(>1条肾动脉或静脉,1个动静脉吻合口[n = 33]),C组(>1条肾动脉或静脉,>1个动静脉吻合口[n = 47])。我们比较了三组在以下方面的情况:患者和移植物存活率、移植后急性肾小管坏死的发生率、血管和泌尿系统并发症、术后平均肌酐水平以及移植后高血压。
我们发现三组在急性排斥反应或急性肾小管坏死的发作方面没有显著差异。所有组的肌酐水平在30天内均恢复正常水平,且无任何显著差异。此外,患者和移植物存活率极佳(分别为100%和97%)。
血管异常的存在及其多次或复杂修复即使在小儿患者中也不构成理论上的劣势。为了最大化供肾的数量和质量,尤其是在小儿群体中,伴有血管异常的肾脏可以在极低风险下进行植入。